The 2nd cycle of the distance learning program “Medical Devices: regulatory requirements, assessment, certification, CE marking” starts on October 18, 2023.
The 10th Aegean Hematology Oncology Symposium will be held on 14-17 September 2023 in Istanbul, Türkiye. The Symposium is categorized and organized as International Congress under the auspices of the Balkan Myeloma Study Group. It is co-organized by the National and Kapodistrian…
Details of the final analysis of the phase III ASPEN trial, which compared zanubrutinib and ibrutinib in symptomatic patients with Waldenström’s macroglobulinemia, were published in the Journal of Clinical Oncology by Meletios A. Dimopoulos, MD, and colleagues.
The University of Texas MD Anderson Cancer Center today was named number one in the nation for cancer care in U.S. News & World Report’s 2023-24 “Best Hospitals” survey. The institution has been one of the nation’s top two hospitals for cancer care since the survey’s…
We are proud to have another publication in WM: “Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study,” (Journal of Clinical Oncology, 21/7/2023)
Federal regulators Thursday approved the first over-the-counter birth control pill available in the United States, a milestone in decades-long efforts to make oral contraceptives easier to obtain, especially by teenagers and women who don’t regularly see a doctor.
Dr Tina Bagratuni and Prof. Meletios A. Dimopoulos were selected for funding from the highly competitive program of International Waldenstrom’s Macroglobulinemia Foundation (IWMF), the IWMF-LLS Strategic Research Roadmap Initiative. The title of the funded project is the “Genomic characterization of ibrutinib-resistant WM”,…
The 16th STATE OF THE ART Adolescent Health/Medicine Congress will be held in Athens on October 13 and 14, 2023, at the NKUA’s ‘Ioannis Drakopoulos’ Amphitheatre. Its main theme will be the ‘Well-being of Children and Adolescents’, and participation will be free of charge.
An important Hemato-Oncology Course was held by the National and Kapodistrian University of Athens in collaboration with Mayo Clinic, USA in Athens from Thursday June 29 to July 1.
3 senior leaders of the MAYO Clinic will share with us their insights on the past, the present and the future of the MAYO Clinic.
The session has ended for security reasons.